. Purpose: Oral contraceptive (OC) use reduces peak aerobic capacity (V O 2peak ); however, whether it also influences adaptations to training has yet to be determined. This study aimed to examine the influence of OC use on peak performance (peak power output [PPO]) and physiological adaptations (V O 2peak and peak cardiac output [Q peak ]) after sprint interval training (SIT) in recreationally active women. Methods: Women taking an OC (n = 25) or experiencing natural regular menstrual cycles (MC; n = 16) completed an incremental exercise test to assess V O 2peak , PPO, and Q peak before, immediately after, and 4 wk after 12 sessions of SIT. The SIT consisted ten 1-min efforts at 100% to 120% PPO in a 1:2 work-rest ratio. Results: Though V O 2peak increased in both groups after SIT (both P G 0.001), the MC group showed greater improvement (OC, +8.5%; MC, +13.0%; P = 0.010). Similarly, Q peak increased in both groups, with greater improvement in the MC group (OC, +4.0%; MC, +16.1%; P = 0.013). PPO increased in both groups (OC, +13.1%; MC, +13.8%; NS). All parameters decreased 4 wk after SIT cessation, but remained elevated from pretraining levels; the OC group showed more sustained training effects in V O 2peak (OC, j4.0%; MC, j7.7%; P = 0.010). Conclusion: SIT improved peak exercise responses in recreationally active women. However, OC use dampened V O 2peak and Q peak adaptation. A follow-up period indicated that OC users had spared V O 2peak adaptations, suggesting that OC use may influence the time course of physiological training adaptations. Therefore, OC use should be verified, controlled for, and considered when interpreting physiological adaptations to exercise training in women. Key Words: AEROBIC CAPACITY, ATHLETIC PERFORMANCE, CARDIAC OUTPUT, DETRAINING, FEMALE, OVARIAN HORMONES E xogenous hormones introduced through oral contraceptive (OC) use may influence endurance exercise performance by reducing maximal exercise capacity (8, 24, 27) , increasing fat mass (5), and changing the metabolic (23), thermoregulatory (36), cardiovascular (12), and ventilatory (9) responses to exercise. Although OC use has been shown to reduce maximal aerobic capacity (V O 2max ) in both highly trained (24) and recreationally active (8, 27) women, whether physiological, cardiovascular, and performance adaptations to endurance exercise training are influenced by OC use remains unclear.
xogenous hormones introduced through oral contraceptive (OC) use may influence endurance exercise performance by reducing maximal exercise capacity (8, 24, 27) , increasing fat mass (5) , and changing the metabolic (23) , thermoregulatory (36) , cardiovascular (12) , and ventilatory (9) responses to exercise. Although OC use has been shown to reduce maximal aerobic capacity (V O 2max ) in both highly trained (24) and recreationally active (8, 27) women, whether physiological, cardiovascular, and performance adaptations to endurance exercise training are influenced by OC use remains unclear.
Near-maximal to maximal interval training, classified as either high-intensity interval training (80%-100% peak HR) or sprint interval training (SIT) (target at or above 100% maximal aerobic capacity) (42) has been extensively studied in both trained and untrained men, with results showing rapid improvements in peak aerobic capacity (V O 2peak ) and endurance performance in as little as 2 wk (1, 7, 18) . Relatively few studies have investigated adaptations to SIT in women (1, 14, 15, 39, 41) . Of these, only one (41) controlled for menstrual cycle (MC) phase, by measuring V O 2peak in the follicular phase (determined by onset of menstruation), yet did not verify serum ovarian hormone concentrations and excluded OC users. Elevated oestradiol and progestin levels in OC attenuate submaximal cardiovascular responses to exercise (25) , potentially by altering fluid retention mechanisms and blood volume changes (37) , and may therefore alter the responses to exercise training in recreationally active women. Whether elevated exogenous oestradiol and progestin levels in OC may alter responses to exercise training and maintenance of adaptations after training in recreationally active women remains to be determined.
To date, only one study has investigated maintenance of training adaptations after SIT in women (31) . Two weeks after completion of SIT, the authors found significant decreases in V O 2max toward baseline, with only 24% of the V O 2max improvements retained. OC use, menstrual status, and/or MC phase were not considered/reported. Therefore, the primary aim of this study was to assess the influence of OC use, compared with natural menstruation, on peak physiological, cardiovascular, and performance adaptations to SIT in recreationally active women while stringently verifying ovarian hormone concentrations. The secondary aim was to investigate the influence of OC use, compared with natural menstruation, on the sustainability of gained adaptations after a 4-wk follow-up.
METHODS
Overview. After a baseline assessment of serum hormone levels and V O 2peak , peak power output (PPO), peak cardiac output (Q peak ), peak stroke volume (SV peak ), peak HR (HR peak ), peak rating of perceived exertion (RPE peak ), peak respiratory quotient (RQ ), and minute ventilation (V E V CO 2slope ), participants with either natural MC (no current hormone contraception) or using an OC completed a 4-wk SIT program with reassessment of all measures after completion of the training program and after a 4-wk follow-up period.
Participants. Healthy, recreationally active (regularly completing at least 150 min of self-reported moderate to vigorous physical activity per week, but not currently training for, or competing at state or national level sport competition) women, who were either long-term (minimum 6 months uninterrupted) monophasic combined OC users (n = 25) or experiencing regular natural MC (n = 22) participated in the study. All experimental procedures were approved by the Human Research Ethics Committee of The University of Queensland, ethical clearance 2012001438, and all participants provided written informed consent.
Nutrition, hydration, and exercise control measures. Before all experimental trials, participants were required to: (a) complete a 24-h food diary and consume, as closely as possible, the same types and quantities of food and beverages the day before testing; (b) fast overnight (Q8 h); (c) consume a standardized moderate carbohydrate (1.5 gIkg j1 body mass carbohydrate) pretrial meal 1 h before arrival at the laboratory for testing; (d) abstain from caffeine, alcohol, and other stimulants and depressants for 24 h, as well as record any additional medications or supplements; and (e) maintain a euhydrated state, avoid hot, humid conditions, and record the volume of water consumed.
Participants were encouraged to maintain their normal physical activity levels throughout the study; however, were asked to refrain from strenuous physical activity for 24 h before each trial to ensure maximal effort. A physical activity questionnaire was completed before each exercise testing session to monitor participants_ activity levels throughout the testing and training period. On the days of testing, participants were requested to arrive at the laboratory in a rested state. A pretrial preparation checklist was completed and signed by participants upon arrival at the laboratory to confirm compliance to pretesting requirements.
Hormone verification and testing. All MC participants completed a MC diary adapted from Prior et al. (30) for three consecutive cycles to determine average cycle length, calculated as the number of days between the onset of consecutive menses. The menstrual diary determined approximate days of follicular and luteal phases, and ovulation (28) . Participants taking an OC mapped their cycle based on their pill packaging, with day 1 of the cycle coinciding with the first inactive (sugar) pill of the package; if a participant reported missing two or more consecutive pills in one cycle, testing was delayed by one cycle until adherence was confirmed.
Urinary ovulation prediction testing was performed during the experimental cycle to verify cycle phase and ovulatory status in the MC group and confirm cycle control by exogenous hormones in the OC group. Participants were provided a home urine ovulation prediction testing kit (Discover 7-Day Pregnancy Planning kit; Church and Dwight Australia Pty Ltd.) and instructed to follow the manufacturer_s directions to perform ovulation prediction testing for seven consecutive days during one cycle. Participants visually inspected the test strip and the result was confirmed by the lead researcher via photographic record. Two days after the urinary luteinising hormone surge, ovulation was assumed to have occurred, with the midluteal phase beginning approximately 6 to 8 d after ovulation. An absence of the luteinising hormone surge during the MC (non-OC use) indicated absence of ovulation. In this case, testing was delayed (n = 3) by a further cycle until a positive ovulation prediction test was recorded. If three consecutive nonovulatory cycles (n = 0) were experienced by participants in the MC group, participants were excluded from the study.
MC participants performed testing during the estimated midluteal phase, 6 to 8 d after a positive ovulation prediction test ovulation (29) . OC participants performed testing in the final 2 wk of the active pill phase (days 15 to 28). On the day of the trial, venous blood (12 mL) was sampled from an antecubital vein for later measurement of serum hormone concentrations. These methods are described in more detail in Schaumberg et al. (34) .
Body composition. Height and body mass were measured using a stadiometer (Seca, Birmingham, UK) and electronic scales (A&D Mercury, Pty Ltd., Thebarton, Australia), respectively. Body composition was assessed by dual-energy x-ray absorptiometry (Hologic Discovery W; QDR 4500A, Waltham, MA). Scans were analyzed using software (APEX version 3.3) provided by the manufacturer (Hologic, Bedford, VA) and according to the manufacturer_s instructions. The coefficients of variation in our laboratory for whole body mass, lean body mass, fat mass, and body fat percentage are 0.1%, 0.4%, 1.2%, and 1.2%, respectively.
Measurement of peak aerobic capacity and PPO. A V O 2peak familiarisation session was completed before the first experimental trial to minimize any learning effects and ensure participant familiarity with the protocol. The V O 2peak protocol involved participants performing a 5-min self-selected warm-up before a continuous incremental ( (33, 38) .
Measurement of cardiovascular parameters. During exercise, HR, stroke volume (SV) and cardiac output (Q ) were measured continuously using impedance cardiology (PhysioFlow ; Manatec Biomedical, France) (10, 32) ; this method has been described elsewhere (10) . Two sets of electrodes (Skintact FS-50, Leonhard Lang Gmbh, Austria)-one transmitting, one sensing-were applied above the supraclavicular fossa at the left base of the neck, and along the xiphoid process. Another two electrodes were used to monitor a single ECG signal (CM5 position). Blood pressure was assessed (Digital blood pressure monitor, UA-767; A&D Instruments Ltd., UK) as part of standard calibration process for the PhysioFlow before the incremental exercise test. HR, SV, and Q data were sampled at 15-s intervals (38) . The coefficient of variation for SV and Q during repeated cycle ergometer V O 2peak tests in healthy, fit men, assessed using the PhysioFlow has been reported as 3.6% and 3.4%, respectively (22) .
SIT protocol. Participants completed three supervised SIT sessions per week for 4 wk, with a minimum of 36 h between sessions. After a 5-min standardized warm-up at an intensity of 50 W and a self-selected revolutions per minute, participants completed the SIT protocol comprising 1 min of work followed by 2 min of passive recovery in a 1:2 workrest ratio (19, 31) . The work interval intensity was selfselected at the maximal sustainable effort between 100% and 120% of PPO determined in the baseline peak exercise test. Participants completed ten 1-min repetitions, totalling 10 min of work per session, with a total time commitment of 40 min per session. Peak HR, RPE, average power output, and PPO were recorded for each interval and used to calculate protocol compliance. All exercise sessions were completed on an air-braked and magnetically braked cycle ergometer (Wattbike Ltd, Nottingham, England). After completion of each SIT session, participants completed a 5-min active cooldown on the cycle ergometer at a self-selected intensity.
Follow-up period. After completion of the 4-wk SIT program, participants were instructed to return to the physical activity levels they were undertaking previous to the SIT protocol. Physical activity was monitored via a questionnaire (Active Australia Survey, Australian Institute of Health and Welfare, 2003) after the duration of the follow-up period. Participants completed testing procedures identical to baseline 4 wk after completion of the SIT training program. Participants were excluded from the follow-up assessment if they commenced or ceased an OC in the preceding month or fell pregnant.
Blood sampling, storage, and analysis. Venous blood was collected into prepared vacuum tubes containing K3EDTA or micronized silica until centrifugation. The serum tubes (micronised silica) were allowed to clot at room temperature, and the plasma tubes (K3EDTA) were stored on ice. After 30 min, samples were centrifuged at 1100g for 10 min at 4-C. Serum and plasma was removed, placed into separate 0.4 mL aliquots and stored at j80-C until later analysis. Plasma samples were analyzed for oestradiol, progesterone and testosterone, whilst serum samples were analyzed for sex-hormone binding globulin (SHBG) using a Cobas e411 electrochemiluminescence immunoassay autoanalyzer (Roche Diagnostics, Germany) and manufacturerrecommended Elecsys assays. Manufacturer-supplied reagents were used, and instruments calibrated according to the manufacturer"s instructions. The coefficients of variation in our laboratory for oestradiol-II, progesterone, testosterone, and SHBG are 3.1%, 5.1%, 4.8%, and 3.1%, respectively.
Statistical analysis. A sample size calculation indicated that to detect a 3.5 mLIkg j1 Imin j1 change in V O 2peak (1 MET) with an SD of 3.5 mLIkg j1 Imin j1 , alpha = 0.05 and power = 80% (effect size = 1), and 30% participant withdrawal before posttesting, a total of 44 participants would be required (22 participants per group) (Power and Sample Size Software, Vanderbilt University, TN). As session attendance was 100%, data were analyzed per protocol using Microsoft Excel 2007 and SPSS (version 22.0, SPSS, Inc., Chicago, IL). Normality of distribution was tested using the Kolmogorov-Smirnov test; when not normally distributed, data were log-transformed and rechecked for normality of distribution. Analyses included standard descriptive statistics, Pearson and Spearman correlation coefficients, paired t test, mixed-model one-way and two-way repeated measures analysis of variance (with a main effect for training-group). To locate the source of significant differences, the Bonferroni post hoc test was used. Homogeneity of variance was confirmed using Mauchly test of sphericity. When the assumption of sphericity was violated (P G 0.05), the F statistic was adjusted using the GreenhouseGeisser correction. Where Mauchly test of sphericity was not found to be significant, post hoc analyses assumed sphericity (40) . Magnitude-based inferences (4, 21) calculated the between-trial standardized differences or effect sizes (95% confidence interval [CI]) using the pooled standard deviation (11) and standard threshold values (3). All tests were two-tailed and statistical significance was set at P G 0.05. Parametric results are given as the mean, standard deviation and 95% CI, [mean T SD (95% CI)]; nonparametric results are given as the median and interquartile range and 95% CI, [median (IQR) (95% CI)] unless stated otherwise.
RESULTS
Participants. Participant recruitment and retention is displayed in Figure 1 . Six of the 22 participants recruited to the MC group were excluded from analysis on the basis of potential luteal phase deficiency (LPD), that is, they did not satisfy the midluteal serum progesterone criterion of 96 ngImL j1 on the day of testing. These participants completed the intervention and a subanalysis of the data are presented in the supplemental content (see Table, Supplemental Digital Content 1, Luteal phase deficient participant demographics, control parameters, body composition, serum hormone concentrations and peak exercise parameters at baseline, after training and after a 4-wk follow-up period, http://links.lww.com/MSS/A819). Therefore, 16 participants who met the progesterone criterion and therefore exhibited normal menstrual function were included in the MC group for analysis. All 25 participants recruited to the OC group were taking a monophasic combined oestradiol and progestin formulation, with a low ethinyl oestradiol (20-30 Kg) and a second-generation or third-generation progestin. There were variations in androgenic (n = 5), antiandrogenic (n = 5), and nonandrogenic (n = 15) formulations (calculated using the method of Greer et al. (20) ) subsequent analyses confirmed androgenicity of OC type (indicative of progestin type and oestradiol ratio) did not influence baseline characteristics or outcome measures.
There were no differences in participant demographics at baseline between groups (P = 0.574-0.988; Table 1 ). Physical activity, energy intake, and body composition parameters were not different within or between groups, at any time point. At baseline, the MC group had significantly higher oestradiol, progestogen and free androgen index (all P G 0.001), and significantly lower SHBG (P G 0.001) concentrations compared with the OC group. There was no difference between groups for total testosterone (P = 0.192). Of the participants identified as LPD, it is interesting to note that these participants were younger, had longer MC, lower body mass and body fat indices, and higher free androgen index than both the OC and MC groups (see Table, Supplemental Digital Content 1, Luteal phase deficient participant demographics, control parameters, body composition, serum hormone concentrations, and peak exercise parameters at baseline, after training and after a 4-wk follow-up period, http://links.lww.com/MSS/A819).
Adherence to protocol. Of the 25 OC participants and 16 MC participants who undertook the training protocol, all participants completed all 12 training sessions and all 120 intervals (i.e., 100% attendance). There were three minor adverse events (one participant fainted during a training session, and one participant had two separate asthma incidents requiring basic first aid). Target power output was achieved in 79.0% of intervals in the OC group and 73.3% of intervals in the MC group; there was no difference between groups. There were also no between-group differences in mean rating of perceived exertion, HR, or power output; results and P values are presented in Table 2 .
Peak aerobic capacity. There was no significant difference between the MC and OC groups for V O 2peak at baseline (t [39] = j0.278; P = 0.783). After training, V O 2peak increased from baseline in both groups (OC; t[24] = j5.108; P G 0.001, MC; t(15) = j11.760; P G 0.001) and remained significantly increased from baseline at follow-up in both groups (OC; t[22] = j3.840; P = 0.001, MC; t[12] = j5.049; P G 0.001); data are presented in Table 2 . The MC group showed greater improvement in V O 2peak after training compared with the OC group (OC +8.5% vs MC +13.0%; F[1,45] = 7.322; P = 0.010), but also a greater decline at follow-up (OC j4.0% vs MC j7.7%; F[1,40] = 6.610; P = 0.014). Standardized between-group differences for withingroup changes (Cohen"s d), presented in Figure 2 , demonstrated that the OC group had a likely lower V O 2peak adaptation to training [j0.22 T 0.18 (j0.40 to j0.04); 0%/40%/60% higher/trivial/lower than MC]. When V O 2peak was adjusted for body mass and lean body mass, the above significant relationships remained true.
PPO. There was no between-group difference for PPO at baseline (t[39] = j0.127; P = 0. Table 2 . Standardized between-group differences for within-group changes (Cohen_s d), presented in Figure 2 , demonstrated a trivial between-group difference in PPO adaptation to training [j0.04 T 0.19 (j0.24 to 0.15); 1%/94%/5% higher/trivial/lower than MC]. Peak cardiac output. There was no significant betweengroup difference in peak cardiac output (Q peak ) at baseline (P = 0.385) or follow-up (P = 0.804), but the MC group demonstrated higher Q peak after training (P = 0.002). After training, Q peak increased in both the OC (t[24] = j3.348; P = 0.003) and MC (t[15] = j6.742; P G 0.001) groups, and returned to pretraining values at follow-up (OC; t[22] = j0.986; P = 0.335, MC; t[13] = j1.735; P = 0.107). There was a significant group-time interaction for the OC group compared with the MC group after training (OC group +4.0% vs MC group +16.1%; F[1,39] = 6.711, P = 0.013); data are presented in Table 2 . There was also a significant group-time interaction for the MC groups versus the LPD subgroup after training (MC group +16.1% vs LPD subgroup +6.3%; F[1,20] = 5.328, P = 0.032); data are presented in the supplemental content (see Table, Supplemental Digital Content 1, Luteal phase deficient participant demographics, control parameters, body composition, serum hormone concentrations and peak exercise parameters at baseline, after training and after a 4-wk follow-up period, http:// links.lww.com/MSS/A819). Standardized between-group differences for within-group changes (Cohen"s d ) demonstrated that the OC group had a likely lower Q peak adaptation to training (j0.51 T 0.39 [j0.90 to j0.12]; 0%/6%/ 94% higher/trivial/lower than MC) compared with the MC group (Fig. 2) .
Peak SV. There was no significant between-group differences in SV peak at any time point (baseline; t Table 3 . Standardized between-group differences for within-group changes (Cohen_s d ) demonstrated .146] = 0.129, P = 0.877); data are presented in Table 3 . Standardized between-group differences for within-group changes (Cohen_s d ) demonstrated that OC use compared with normal menstrual function had a possibly trivial effect on RQ adaptation to training [0.02 T 0.52 (j0.50 to 0.54); 24%/56%/20% higher/trivial/lower than MC] (Fig. 2) .
Minute ventilation. There was no significant betweengroup difference in V E V CO 2slope at each time point (baseline; Table 3 . Standardized between-group differences for within-group changes (Cohen_s d) demonstrated that OC use compared with normal menstrual function had a possibly trivial effect on V E V CO 2slope adaptation to training (0.09 T 0.45 [j0.36 to 0.54]; 31%/59%/10% higher/trivial/ lower than MC) (Fig. 2) .
Peak HR and rating of perceived exertion. There was no significant difference between MC and OC group for HR peak or RPE peak at each of the three time points (all P 9 0.05). There were no differences in HR peak or RPE peak pretraining, posttraining, or detraining in the OC and MC groups (all P 9 0.05). There was no significant group-time interaction for HR peak 
DISCUSSION
The present study assessed the influence of OC use on peak physiological adaptations (V O 2peak , PPO, Q peak , SV peak , RQ , HR peak , RPE peak , and V E V CO 2slope ) to 4 wk of SIT in recreationally active women under stringently controlled ovarian hormone conditions. Additionally, the maintenance of these adaptations during a 4-wk follow-up period after SIT was assessed. This study found that OC use, compared to normal menstruation, dampened V O 2peak and Q peak adaptations to SIT in recreationally active women, but did not influence PPO or other adaptations. Interestingly, OC use appeared to protect against the loss of peak physiological Parametric data are presented as mean T SD (95% CI); nonparametric data are presented as median [IQR] (95% CI).
*P G 0.01 vs pre. **P G 0.01 vs post. ***P G 0.05 vs pre.
and performance adaptations during the 4-wk follow-up period. This is the first study to investigate the influence of OC use on peak exercise adaptations to training. The magnitude of improvement in V O 2peak in the OC (8.5%), MC (13.0%), and LPD (13.6%) groups in the present study are similar to those previously reported in recreationally active women for whom hormone levels were not established. Indeed, several SIT studies in recreationally active women have found that 2 to 8 wk of SIT comprising four to 10 bouts of 30 s to 4 min in duration (variable intensity) with 1-to 4-min rest have elicited significant (P G 0.05) improvements of 6.5% to 14.0% in V O 2max (1,14,15,31,39,41 ). Of these, only one study (41) , excluding OC users, attempted to control for MC phase by testing in the follicular phase (determined by onset of menstruation), yet did not verify MC phase using hormone measures. With up to 57% of reproductive-age women in worldwide reporting OC use (16) , it is likely that the majority of participants within these studies were taking an OC. Therefore, the findings of the present study suggest that the V O 2peak adaptation reported within these previous studies, where no consideration of OC use or ovarian hormone concentrations in the methodology is apparent, were likely influenced by OC use. However, it must be noted that there is a wide array of hormone contraceptives in use. As this study specifically investigation low-dose combined OC, with 20 to 30 Kg ethinyl estradiol and a second or third generation progestin, this conclusion cannot yet be drawn for higher dose formulations and OC that use earlier or later generation progestins. Furthermore, while not statistically significant, it is important to note that, on average, the OC group lost weight over the duration of the study, while the MC group and LPD subgroup gained a small amount of weight. When variables of interest were adjusted for body mass and lean body mass, the interactions remained true. Therefore, it is unlikely that these small, nonsignificant changes in body mass influenced the outcomes of the study. The significant improvement demonstrated by the LPD subgroup, despite their lower body mass provide compelling evidence that the lower V O 2peak adaptation in the OC group is an actual finding and not an artefact of the small nonsignificant differences in body mass between groups.
Normative data developed for women must also be interpreted carefully, and the threshold improvement for V O 2peak as a marker of cardiorespiratory fitness and/or health may need to consider OC use or ovarian hormone status during interpretation. Furthermore, OC status should be considered by coaches and sports scientist when interpreting physiological responses to training blocks, and the utilisation of measures and standards that are not influenced by ovarian hormone status should be a priority within femalespecific populations.
In the one study reporting repeated measures of V O 2peak during a follow-up period, Ready and colleagues (31) observed that only 24% of the improvements in V O 2peak after training were maintained after a 2-wk follow-up. However, the authors did not consider/report OC use or menstrual status. Results of the present study suggest that while OC use dampens V O 2peak adaptation after a training intervention, it may also minimize the loss of the training effect for the parameter. V O 2peak returned towards baseline after follow-up in both groups; however, OC users retained 93% of V O 2peak adaptations to training, compared to naturally menstruating women, who retained 41% of the V O 2peak adaptation to training. It is important to note that while the OC group demonstrated lower V O 2peak adaptations to training, and therefore may have been expected to exhibit lower decline towards baseline, both groups had similar percentage improvements in V O 2peak at follow-up (both approximately 4.4%). Therefore, OC use may alter the time course of training adaptations, and the use of OC during lower training periods, tapering or injury, may indeed be a useful practise to minimize the negative effects of detraining. Inclusion of longer training and follow-up periods with intermediate testing would shed further light on this phenomenon.
Furthermore, it must also be noted that participants in the present study were already physically active, and were encouraged to maintain their habitual levels of physical activity throughout training and follow-up, and merely refrain from performing SIT during the follow-up phase. Therefore, results from the present study may not be comparable to studies where habitual exercise was completely ceased. Furthermore, while not statistically significant, there was an average of 18 minIwk j1 difference in physical activity levels between the OC and MC groups at follow-up. Additionally, the LPD group reported similar physical activity to the OC group at baseline, and only slightly higher physical activity than the MC group at follow-up. These observations align with the changes in V O 2peak after detraining (MC; +7.9% and LPD; +8.4%, compared with OC; +3.6%). Whilst this nonsignificant between-group difference in physical activity levels is likely negligible on a day-to-day basis, it may have contributed to the different responses observed in the loss of peak exercise after follow-up between groups.
There is significant evidence to suggest that changes in peak cardiac output, specifically related to changes in blood volume and SV, are a strong influencing factor on V O 2peak adaptation (2) . Longitudinal studies have demonstrated that training-induced increases in V O 2peak result primarily from an increase in maximal cardiac output, rather than a widening of the arteriovenous oxygen difference, suggesting that V O 2peak training adaption is predominantly related to central adaptations rather than peripheral adaptation (2). After SIT, there was a significant increase in Q peak of +4.0% and +16.1% in the OC group and the MC group, respectively, with the MC group showing a significantly greater improvement (P = 0.013). At follow-up, Q peak returned towards pretraining levels in both groups, and there were no between-group differences at follow-up. When considered in conjunction with the significant positive relationship between change in V O 2peak and change in Q peak with training (r = 0.362, P = 0.020), this, at least in part, explains the dampened V O 2peak response to training observed in OC users compared to naturally menstruating women.
Reductions in blood volume and cardiac output have previously been found after detraining in men and women (13, 26) , and have previously been suggested to explain the loss of V O 2peak during follow-up. However, changes in cardiac output only partially explain the observed changes in V O 2peak with training. The effects of oestrogen and progesterone on plasma volume expansion and fluid retention [through the potential mechanisms of capillary filtration/ permeability and stimulation of nitric oxide production and subsequent effect on the renin-angiotensin aldosterone system (9)] may explain why the OC group showed a practically meaningful (though not statistically significant) lower decline in Q peak (due to potential preservation of traininginduced blood volume changes) 4 wk after the completion of SIT training (4.0% in the OC group vs 7.7% in the MC group) (35) . However, central adaptations including changes in cardiac output and SV seen in the present study do not completely explain the change in V O 2peak with training, therefore further research should investigate peripheral adaptations, such as peripheral muscle deoxygenation or mitochondrial oxidative capacity, which may be associated with the discrepancy in physiological adaptations to exercise training between naturally menstruating women and OC users.
It is a further interesting finding of this investigation that the luteal phase deficient women excluded from primary analyses demonstrated dampened Q peak adaptations to training in a similar manner to the OC group (both compared to the group with normal menstrual function). This result (see Table, Supplemental Digital Content 1, Luteal phase deficient participant demographics, control parameters, body composition, serum hormone concentrations and peak exercise parameters at baseline, after training and after a 4-wk follow-up period, http://links.lww.com/MSS/A819) provides preliminary evidence that LPD significantly influences cardiovascular adaptations to training. This suggests that circulating endogenous ovarian hormone concentrations may be more influential on adaptation to training compared to exogenous ovarian hormones. Indeed, previous research has demonstrated that high oestrogen and progesterone levels are independently associated with plasma volume expansion (37) , in comparison to primarily circulating exogenous hormones (35) . In contrast to previous speculation that the cardiovascular limitation to exercise training adaptation in OC users is primarily due to the influence of exogenous oestradiol on the cardiovascular system, this finding suggests that it may instead be the low endogenous oestradiol concentrations that are implicated.
Both OC and MC groups improved PPO by 13.1% and 13.8%, respectively, with no difference between groups. After a 4-wk follow-up period, PPO returned towards baseline, with just over half of the PPO adaptation preserved in both groups. As PPO is strongly correlated with exercise performance (17) , the present data suggest performance adaptations to SIT, and the preservation of these adaptations after SIT, are not influenced by OC use. Therefore, depending on the aims of an intervention, it may be more appropriate to use nonphysiological measures of performance, such as PPO, when assessing adaptation to training in women who have varied hormone status, due to the apparent impact of OC use on physiological parameters after a training intervention. However, further research investigating performance in competitive athletic women using sport-specific contexts and/or time trials is needed to confirm this. There were no significant changes in peak HR, RPE, RQ and V E V O 2slope follow training, and no differences between groups were observed. While there were no significant between-group differences in SV adaptations to training, the transient effect of both endogenous and exogenous progestogens on HR may have masked any potential changes in peak HR and SV after training.
We recognize several limitations of the present study. It is a notable limitation of the present study that no nonexercising control group was included, therefore the changes seen with training must be interpreted with caution. All participants were taking a monophasic OC; however, there were variations in androgenic (n = 5), anti-androgenic (n = 5) and nonandrogenic (n = 15) formulations. Although no differences in training adaptations were present among the different OC formulations, the small sample size after subgrouping may have limited our ability to detect differences; further investigation is necessary to confirm whether OC androgenicity influences adaptation to training in women. Second, after training, the oestrogen and progesterone concentrations of women with normal menstrual function were significantly lower. Despite the challenges it posed, we chose to test within the midluteal phase within this study to ensure that endogenous ovarian hormones were as high as possible and compare to OC use when exogenous hormones were as high as possible and endogenous hormones were as low as possible to maximise the effect of ovarian hormones on outcome measures. Although we are confident that the timing of testing, based on individual participant cycle lengths, was appropriate, it is possible that the sudden perturbation in energy balance caused by the SIT program induced probably LPD within subsequent cycles in some women which is an important consideration for future training studies in women. Therefore, to minimize the influence of fluctuating ovarian hormones on study outcomes, it may be more practical to test in the early follicular phase during training interventions that could elicit LPD in at risk women.
Third, although self-report physical activity during the 4-wk period after completion of SIT training was not different between groups, objective monitoring would have minimized any potential recall bias associated with self-report measures. Finally, after serum hormone analyses, six naturally menstruating women who completed the training intervention were excluded from the primary analysis as they did not meet the minimum progesterone concentration criterion for normal midluteal menstrual phase. Therefore, we recommend oversampling by 30% in normally menstruating participants in studies including women, to account for the required exclusion of potential luteal phase deficient participants from analysis. We have presented supplementary data which suggests that luteal phase deficiency may indeed influence cardiovascular adaptation to training. Whether forms of menstrual dysfunction influence adaptation to training is an important consideration in the area of female athletic performance and adaptation to training in physically active women, and requires further investigation.
In conclusion, this study suggests that compared with natural menstruation, OC use dampens V O 2peak and Q peak adaptation to SIT in recreationally active women, yet better preserves these adaptations after completion of SIT training, particularly for V O 2peak . In contrast, PPO adaptation appeared unaffected by OC use. These findings demonstrate the clear need to consider exogenous hormone use in exercise training studies involving women of reproductive age. Further investigation is required to elucidate the influences of OC use compared with natural menstruation on the central and peripheral adaptations to exercise training, and how these may manifest in exercise performance.
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